Molecular characterization of the diabetes-associated mouse MHC class II protein, I-A(g7)

被引:72
作者
Reizis, B
Eisenstein, M
Bockova, J
KonenWaisman, S
Mor, F
Elias, D
Cohen, IR
机构
[1] WEIZMANN INST SCI,DEPT IMMUNOL,IL-76100 REHOVOT,ISRAEL
[2] WEIZMANN INST SCI,CHEM SERV,IL-76100 REHOVOT,ISRAEL
关键词
autoimmunity; non-obese diabetic mice; peptides;
D O I
10.1093/intimm/9.1.43
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The MHC class II molecule of the non-obese diabetic (NOD) mice, I-A(g7), is associated with susceptibility to autoimmune diabetes, To try to understand the molecular basis of this association, we analyzed the peptide binding properties and intracellular behavior of I-A(g7) in comparison with other I-A haplotypes, We found that I-A(g7) molecules manifested normal intracellular trafficking and lifespan, and a small but clearly detectable fraction of I-A(g7) in the cells formed SDS-resistant compact dimers, The binding of an antigenic reference peptide to I-A(g7) was stable and was accompanied by compact dimer formation, Our analysis of the binding specificity of I-A(g7) revealed a peptide binding motif of nine amino acids with a degenerate position at P1 and three conserved anchor positions: P4, P6 and P9, An allele-specific preference for negatively charged residues was found at P9, apparently due to the presence of the rare Ser residue at position 57 of the I-A(g7) beta chain, These findings could have implications for the mechanisms of MHC-mediated susceptibility to autoimmune diabetes in the NOD mice.
引用
收藏
页码:43 / 51
页数:9
相关论文
共 36 条
[1]   THE 1ST EXTERNAL DOMAIN OF THE NONOBESE DIABETIC MOUSE CLASS-II I-A BETA-CHAIN IS UNIQUE [J].
ACHAORBEA, H ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) :2435-2439
[2]  
Amor S, 1996, J IMMUNOL, V156, P3000
[3]   INSULIN-DEPENDENT DIABETES-MELLITUS AS A BETA-CELL TARGETED DISEASE OF IMMUNOREGULATION [J].
BACH, JF .
JOURNAL OF AUTOIMMUNITY, 1995, 8 (04) :439-463
[4]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[5]   Developing and shedding inhibitions: How MHC class II molecules reach maturity [J].
Busch, R ;
Mellins, ED .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (01) :51-58
[6]   THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES [J].
BUUS, S ;
SETTE, A ;
COLON, SM ;
MILES, C ;
GREY, HM .
SCIENCE, 1987, 235 (4794) :1353-1358
[7]  
CarrascoMarin E, 1996, J IMMUNOL, V156, P450
[8]  
DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430
[9]   DETERMINANT CAPTURE AS A POSSIBLE MECHANISM OF PROTECTION AFFORDED BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES IN AUTOIMMUNE-DISEASE [J].
DENG, HK ;
APPLE, R ;
CLARESALZLER, M ;
TREMBLEAU, S ;
MATHIS, D ;
ADORINI, L ;
SERCARZ, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1675-1680
[10]   VACCINATION AGAINST AUTOIMMUNE MOUSE DIABETES WITH A T-CELL EPITOPE OF THE HUMAN 65-KDA HEAT-SHOCK PROTEIN [J].
ELIAS, D ;
RESHEF, T ;
BIRK, OS ;
VANDERZEE, R ;
WALKER, MD ;
COHEN, IR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) :3088-3091